title: Low incidence of retinopathy during peginterferon alpha-2b and lamivudine therapy for chronic hepatitis B.
authors.forename: Erik H C J
authors.initials: EH
authors.lastname: Buster
authors.forename: Martijn J
authors.initials: MJ
authors.lastname: Ter Borg
authors.forename: Johannes R
authors.initials: JR
authors.lastname: Vingerling
authors.forename: Harry L A
authors.initials: HL
authors.lastname: Janssen
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D005074:Evoked Potentials, Visual / Q000187:drug effects; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D015994:Incidence; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D019259:Lamivudine / Q000009:adverse effects* / Q000627:therapeutic use; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012164:Retinal Diseases / Q000139:chemically induced* / Q000453:epidemiology / Q000503:physiopathology; D012307:Risk Factors
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D019259:Lamivudine; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b